Neurochemical Differences between 1p/19q Codeleted and Noncodeleted IDH-mutant Gliomas by in Vivo MR Spectroscopy.
Journal
Radiology
ISSN: 1527-1315
Titre abrégé: Radiology
Pays: United States
ID NLM: 0401260
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
pmc-release:
01
09
2024
medline:
6
9
2023
pubmed:
5
9
2023
entrez:
5
9
2023
Statut:
ppublish
Résumé
Background Noninvasive identification of glioma subtypes is important for optimizing treatment strategies. Purpose To compare the in vivo neurochemical profiles between isocitrate dehydrogenase (IDH) 1-mutant 1p/19q codeleted gliomas and their noncodeleted counterparts measured by MR spectroscopy at 3.0 T with a point-resolved spectroscopy (PRESS) sequence optimized for D-2-hydroxyglutarate (2HG) detection. Materials and Methods Adults with
Identifiants
pubmed: 37668523
doi: 10.1148/radiol.223255
pmc: PMC10546286
doi:
Substances chimiques
Creatine
MU72812GK0
Cystathionine
375YFJ481O
Receptors, Antigen, T-Cell
0
Water
059QF0KO0R
Banques de données
ClinicalTrials.gov
['NCT01703962']
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e223255Subventions
Organisme : NINDS NIH HHS
ID : P30 NS076408
Pays : United States
Organisme : NIBIB NIH HHS
ID : P41 EB015894
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA269110
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
Neuro Oncol. 2018 Jan 10;20(1):103-112
pubmed: 29016833
Magn Reson Med. 2000 Feb;43(2):319-23
pubmed: 10680699
Magn Reson Med. 2007 Feb;57(2):308-18
pubmed: 17260370
Am J Pathol. 1994 Nov;145(5):1175-90
pubmed: 7977648
N Engl J Med. 2015 Jun 25;372(26):2499-508
pubmed: 26061753
AJNR Am J Neuroradiol. 2018 Apr;39(4):687-692
pubmed: 29519793
Magn Reson Med. 2015 Jun;73(6):2094-9
pubmed: 25046359
Nat Med. 2012 Jan 26;18(4):624-9
pubmed: 22281806
J Magn Reson. 2010 Feb;202(2):259-66
pubmed: 20005139
Magn Reson Med. 2019 Oct;82(4):1259-1265
pubmed: 31131476
Clin Cancer Res. 2017 Oct 15;23(20):6078-6085
pubmed: 28751449
NMR Biomed. 2000 May;13(3):129-53
pubmed: 10861994
Cancers (Basel). 2021 Jan 23;13(3):
pubmed: 33498680
Cell Rep Med. 2021 Dec 21;2(12):100469
pubmed: 35028610
Ann Oncol. 2019 Aug 1;30(8):1265-1278
pubmed: 31124566
Curr Opin Neurol. 2020 Aug;33(4):413-421
pubmed: 32657882
J Natl Cancer Inst. 1998 Oct 7;90(19):1473-9
pubmed: 9776413
AJNR Am J Neuroradiol. 2013 Jul;34(7):1326-33
pubmed: 23221948
Nature. 2009 Dec 10;462(7274):739-44
pubmed: 19935646
Am J Pathol. 2009 Apr;174(4):1149-53
pubmed: 19246647
AJNR Am J Neuroradiol. 2019 Mar;40(3):426-432
pubmed: 30705071
J Clin Oncol. 2016 Nov 20;34(33):4030-4039
pubmed: 28248126
Neuro Oncol. 2019 Jun 10;21(6):765-774
pubmed: 30726924
Magn Reson Med. 2006 Feb;55(2):250-7
pubmed: 16402370
Nucleic Acids Res. 2009 Jan;37(Database issue):D603-10
pubmed: 18953024
Magn Reson Med. 1999 Apr;41(4):649-56
pubmed: 10332839
Tomography. 2016 Jun;2(2):94-105
pubmed: 27547821
J Neuropathol Exp Neurol. 2017 May 1;76(5):342-346
pubmed: 28419269
Br J Radiol. 2016;89(1060):20150857
pubmed: 26849038
Magn Reson Med. 1993 Dec;30(6):672-9
pubmed: 8139448
J Biol Chem. 2006 Nov 24;281(47):35785-93
pubmed: 17005561
Neuro Oncol. 2021 Aug 2;23(8):1231-1251
pubmed: 34185076
Magn Reson Med. 2018 Mar;79(3):1260-1265
pubmed: 28691380
J Magn Reson Imaging. 2004 May;19(5):537-45
pubmed: 15112302
NMR Biomed. 1998 Oct;11(6):266-72
pubmed: 9802468
Magn Reson Med. 2022 Aug;88(2):537-545
pubmed: 35381117
N Engl J Med. 2009 Feb 19;360(8):765-73
pubmed: 19228619
Neuro Oncol. 2018 Jun 18;20(7):907-916
pubmed: 29126125
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931